Medicine price: quote on request. Your total cost is quoted in writing per case.
We give you a written timeline estimate for your case before you commit.Ask about Jascayd

Is Jascayd available in Saudi Arabia? Status, route and cost

A plain answer for families in Saudi Arabia, checked against FDA, regulator and manufacturer sources on 17 October 2026.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Is Jascayd available in Saudi Arabia?

Jascayd is not in SFDA's public Drugs List (checked 17 October 2026). It is a twice-daily tablet for idiopathic and progressive pulmonary fibrosis. The legal route is a named-patient request: a licensed Saudi hospital asks SFDA to import it for one patient, using the FDA approval as the reference.

Registration: Not in SFDA's public Drugs List, checked 17 October 2026.
Access route: Hospital import request to SFDA for one named patient, using the FDA approval.
Who acts: a licensed Saudi hospital, on the written request of your treating consultant.
Timeline: We give you a written timeline estimate for your case before you commit.
Price: Medicine price: quote on request. You get a written quote for your case before you commit.

Status in Saudi Arabia, with dates

Not found in SFDA's public Drugs List (all 9,173 entries searched by brand and generic name), checked 17 October 2026. (source)
In the region, Jascayd has two active codes in the Abu Dhabi Department of Health drug code list, release of 26 September 2026. (source)
FDA approval for IPF on 7 October 2025. (source)
FDA approval for PPF in December 2025. (source)

What Jascayd is

Jascayd (nerandomilast) is a tablet made by Boehringer Ingelheim. It is a phosphodiesterase 4B (PDE4B) inhibitor. The FDA approved it on 7 October 2025 for idiopathic pulmonary fibrosis (IPF) in adults, and in December 2025 for progressive pulmonary fibrosis (PPF) in adults. The pivotal trial for PPF was FIBRONEER-ILD.

Pulmonary fibrosis is scarring of the lungs that makes breathing harder over time. Jascayd is a long-term treatment that a lung specialist starts and follows up.

How it is given and safety

The usual dose is 18 mg by mouth twice daily, about 12 hours apart, with or without food. The tablet can be swallowed whole or dispersed in water. The dose is lowered to 9 mg twice daily for people who cannot tolerate 18 mg (but not for people also taking pirfenidone, who stay on 18 mg) and for people taking strong CYP3A inhibitors. Tablets come in 9 mg and 18 mg strengths.

The US label lists no contraindications. Common side effects reported by Boehringer Ingelheim include diarrhea, COVID-19, upper respiratory infections, depression, weight loss, decreased appetite, nausea, tiredness, headache, vomiting, back pain and dizziness. Diarrhea was more frequent in people also taking nintedanib, and it was the most common reason to stop treatment.

How access works in Saudi Arabia

Because Jascayd is approved by the US FDA, a licensed Saudi hospital can ask SFDA for permission to import it for one named patient. This is often called the named-patient route.

SFDA expects the medicine to be registered with at least one reference regulator, such as the US FDA or the European Medicines Agency. The hospital signs a declaration that it takes responsibility for safe use. A licensed importer signs a declaration covering quality during transport. The patient or a legal guardian gives written consent after the treating doctor explains the benefits and risks.

SFDA's Special Access Program is a different route, for medicines with no reference approval anywhere, such as products still in clinical trials. Jascayd does not need that route because it already has FDA approval.

Public lists can lag behind registration decisions, so the hospital pharmacy confirms the status in SFDA's system before anything is filed.

Who does what

Your treating specialist decides whether Jascayd is right for the patient and writes the clinical letter and prescription.
The hospital files the import request, receives the medicine and dispenses it to the patient.
The Saudi Food and Drug Authority (SFDA) registers medicines and decides on any import request for a medicine that is not registered.
Boehringer Ingelheim makes Jascayd and decides where it is supplied.
Reserve Meds helps your family understand the steps, organizes records and communication, and, where an import is approved, arranges US supply through our licensed wholesale partner. We do not give medical advice.

Documents you will usually need

The lung specialist's report confirming IPF or PPF, with the high-resolution CT report
Recent lung function test results
A list of current medicines, especially pirfenidone, nintedanib or any strong CYP3A inhibitor, because they change the dose plan
For an import request: the hospital's request form, its signed declaration of responsibility, written patient consent, and proof of the US FDA approval (we can supply the US prescribing information)

Steps

Doctor's letter. Your specialist writes the clinical letter and prescription.
Hospital request. The hospital pharmacy files the import request with SFDA.
Regulator decision. SFDA reviews the request and approves it or asks for more information.
US sourcing. Our US-licensed wholesale partner supplies the medicine, shipped with tracking.
Hospital receipt. The hospital pharmacy receives the medicine and dispenses it to the patient.

Timeline and cost

We give you a written timeline estimate for your case before you commit. The regulator, the hospital and the manufacturer set their own timelines.

Medicine price: quote on request. You get a written quote for your case before you commit. Your total cost depends on the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We coordinate access to FDA-approved medicines only. We help your family understand the route, organize records and communication with the doctor and hospital, and, where an import is approved, arrange US supply and shipping through our licensed wholesale partner. Delivery follows the terms of the import approval and is confirmed in writing before you commit. We do not prescribe, and we do not decide what SFDA approves.

Ask about Jascayd in Saudi Arabia

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Frequently asked questions

Is Jascayd registered in Saudi Arabia?

Jascayd is not in SFDA's public Drugs List (checked 17 October 2026). Public lists can lag behind registration decisions, so the hospital pharmacy confirms the status in SFDA's system before anything is filed.

How do patients in Saudi Arabia get Jascayd?

Because Jascayd is approved by the US FDA, a licensed Saudi hospital can ask SFDA for permission to import it for one named patient. This is often called the named-patient route. SFDA expects the medicine to be registered with at least one reference regulator, such as the US FDA or the European Medicines Agency. The hospital signs a declaration that it takes responsibility for safe use. A licensed importer signs a declaration covering quality during transport. The patient or a legal guardian gives written consent after the treating doctor explains the benefits and risks.

How long does it take to get Jascayd in Saudi Arabia?

We give you a written timeline estimate for your case before you commit. The regulator, the hospital and the manufacturer set their own timelines, and we tell you honestly what depends on them.

How much does Jascayd cost?

Medicine price: quote on request. You get a written quote for your case before you commit. Your total cost, including shipping, import steps and coordination, is quoted in writing before you commit. No hidden charges.

Can Jascayd be taken with nintedanib or pirfenidone?

The US label covers people who also take pirfenidone: they stay on 18 mg twice daily. Boehringer Ingelheim reported that diarrhea was more frequent in people also taking nintedanib. Your lung specialist decides on the combination and the dose.

Sources

Checked on 17 October 2026. Regulator rules and lists change. Your doctor, hospital pharmacy or the regulator confirms the current position before anything is filed.